SAN DIEGO–(BUSINESS WIRE)–Nuvve Holding Corp. (Nasdaq: NVVE) (“Nuvve” or the “Company”) wishes its stockholders to vote at the upcoming Special Meeting of Stockholders (the “Special Meeting”) on January 13, 2025 at 1:00 p.m. Eastern (10:00 a.m. Pacific) Time. The methods of voting and submission of proxies are described in the distributed proxies materials for the extraordinary meeting.
The record date for the Special Meeting is December 6, 2024. If any stockholder needs assistance voting their shares, please contact Advantage Proxy, Inc. toll-free at 1-877-870-8565 or by email at ksmith@advantageproxy .com.
Nuvve requests that all shareholders vote their proxies, regardless of how many shares they own. Nuvve strongly encourages all of its stockholders to read the company’s definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission (“SEC”) on December 16, 2024 (the “Proxy Statement”), which is available free of charge at the SEC’s website at www.sec.gov.
About Nuvve
Nuvve (Nasdaq: NVVE) is a global technology leader accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) platform. Nuvve’s mission is to reduce the cost of electric vehicle ownership while supporting the integration of renewable energy sources, including solar and wind. For more information visit nuvve.com.
Nuvve statements about the future
This press release contains forward-looking statements or forward-looking information within the meaning of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of expressions that refer to future such as “may,” “will,” “expects,” “believes,” “aims,” ”expects,” “plans,” “looks forward to,” “estimates,” “projects,” “assumes,” ” guides”, “goals”, “forecasts”, “continuing”, “seek” or negative words of such terms or other variations of such terms or comparable terminology, although not all forward-looking statements contain such identifying words. Forward-looking statements include, but are not limited to, statements regarding expectations, plans, intentions, strategies, prospects, business plans, product and service offerings, new product launches, potential clinical successes and other statements that are not historical facts. . . Nuvve cautions you that these forward-looking statements are subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond Nuvve’s control. Such statements are based on management’s current beliefs and expectations and are subject to significant risks and uncertainties that could cause actual outcomes and results to differ materially. Some of these risks and uncertainties can be found in Nuvve’s most recent Annual Report on Form 10-K and subsequent periodic reports filed with the Securities and Exchange Commission (SEC). Copies of these submissions are available online at www.sec.gov, https://investors.nuvve.com/ or upon request from Nuvva. These factors should not be construed as exhaustive and should be read in conjunction with other cautionary statements included in Nuvve’s filings with the SEC. Such forward-looking statements speak only as of the date they are made, and Nuvve disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers of this press release are cautioned not to place undue reliance on these forward-looking statements, as there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement applies to all forward-looking statements contained in this press release.
See the original version on businesswire.com: https://www.businesswire.com/news/home/20250110415581/en/
Nuvve Contact for investors
investorrelations@nuvve.com
+1 (619) 483-3448
Nuvve Press contacts
press@nuvve.com
+1 (619) 483-3448
Source: Nuvve Holding Corp.
